Literature DB >> 29949380

Choice of Initial Oral Therapy for Pulmonary Arterial Hypertension: Age and Long-Term Survival.

Gustavo A Heresi1, Thomas E Love2, Adriano R Tonelli1, Kristin B Highland1, Raed A Dweik1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29949380      PMCID： PMC6221567          DOI： 10.1164/rccm.201801-0059LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  9 in total

1.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Respir J       Date:  2015-08-29       Impact factor: 16.671

2.  Time to consider death in clinical trials for PAH.

Authors:  Paul M Hassoun
Journal:  Lancet Respir Med       Date:  2016-10-11       Impact factor: 30.700

3.  Race and sex differences in response to endothelin receptor antagonists for pulmonary arterial hypertension.

Authors:  Nicole B Gabler; Benjamin French; Brian L Strom; Ziyue Liu; Harold I Palevsky; Darren B Taichman; Steven M Kawut; Scott D Halpern
Journal:  Chest       Date:  2011-09-22       Impact factor: 9.410

4.  Sex differences in response to tadalafil in pulmonary arterial hypertension.

Authors:  Stephen C Mathai; Paul M Hassoun; Milo A Puhan; Yi Zhou; Robert A Wise
Journal:  Chest       Date:  2015-01       Impact factor: 9.410

Review 5.  Combination Therapy for Pulmonary Arterial Hypertension: A Systematic Review and Meta-analysis.

Authors:  Benjamin D Fox; Osnat Shtraichman; David Langleben; Avi Shimony; Mordechai R Kramer
Journal:  Can J Cardiol       Date:  2016-03-17       Impact factor: 5.223

Review 6.  Combination therapy versus monotherapy for pulmonary arterial hypertension: a meta-analysis.

Authors:  Annie Christine Lajoie; Gabriel Lauzière; Jean-Christophe Lega; Yves Lacasse; Sylvie Martin; Serge Simard; Sebastien Bonnet; Steeve Provencher
Journal:  Lancet Respir Med       Date:  2016-02-27       Impact factor: 30.700

7.  Initial combination therapy with ambrisentan and tadalafil and mortality in patients with pulmonary arterial hypertension: a secondary analysis of the results from the randomised, controlled AMBITION study.

Authors:  Marius M Hoeper; Vallerie V McLaughlin; Joan Albert Barberá; Adaani E Frost; Hossein-Ardeschir Ghofrani; Andrew J Peacock; Gérald Simonneau; Stephan Rosenkranz; Ronald J Oudiz; R James White; Karen L Miller; Jonathan Langley; Julia H N Harris; Christiana Blair; Lewis J Rubin; Jean-Luc Vachiery
Journal:  Lancet Respir Med       Date:  2016-10-11       Impact factor: 30.700

8.  Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension.

Authors:  Raymond L Benza; Mardi Gomberg-Maitland; Teresa Demarco; Adaani E Frost; Adam Torbicki; David Langleben; Tomas Pulido; Priscilla Correa-Jaque; Michael J Passineau; Howard W Wiener; Mayumi Tamari; Tomomitsu Hirota; Michiaki Kubo; Hemant K Tiwari
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

9.  Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.

Authors:  Nazzareno Galiè; Joan A Barberà; Adaani E Frost; Hossein-Ardeschir Ghofrani; Marius M Hoeper; Vallerie V McLaughlin; Andrew J Peacock; Gérald Simonneau; Jean-Luc Vachiery; Ekkehard Grünig; Ronald J Oudiz; Anton Vonk-Noordegraaf; R James White; Christiana Blair; Hunter Gillies; Karen L Miller; Julia H N Harris; Jonathan Langley; Lewis J Rubin
Journal:  N Engl J Med       Date:  2015-08-27       Impact factor: 91.245
  9 in total
  1 in total

1.  Monotherapy in patients with pulmonary arterial hypertension at four German PH centres.

Authors:  Beate Stubbe; Hans-Jürgen Seyfarth; Janina Kleymann; Michael Halank; Hussam Al Ghorani; Anne Obst; Susanna Desole; Ralf Ewert; Christian F Opitz
Journal:  BMC Pulm Med       Date:  2021-04-21       Impact factor: 3.317
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.